文献速递瓣膜病与结构性心脏病

再次二尖瓣手术的当代结局

Contemporary outcomes in reoperative mitral valve surgery.
PubMed 文献 · Heart · 2017-10-05

基于地区STS数据库11 973例开放二尖瓣手术(2002-2016)分析,其中9.7%为再次手术;再次手术患者术前合并症更多、并发症与手术死亡率更高(11.1% vs 6.5%,p<0.0001),但随手术量每年增长10%,手术死亡率O/E比从早期1.44改善至近期0.72。

要点

  • 再次二尖瓣手术约占二尖瓣手术的10%,风险与资源利用均高于首次手术。
  • 心源性休克、重度三尖瓣反流、急诊状态及合并CABG独立增加主要并发症与30天死亡风险。
  • 再次二尖瓣手术量每年增长10%,手术死亡率O/E比由1.44改善至0.72。

核心结论

  • 再次二尖瓣手术约占二尖瓣手术的10%,与风险和资源利用增加相关,但随着手术量增加,结局已显著改善并优于预测。

研究设计与样本

  • 回顾性分析地区胸外科医师学会(STS)数据库2002-2016年全部11 973例开放二尖瓣手术病例,按首次与再次二尖瓣手术分层。

主要发现

  • 1096例(9.7%)有既往二尖瓣手术史,再次手术患者瓣膜置换率及术前合并症更高,并发症、手术死亡率(11.1% vs 6.5%,p<0.0001)和资源利用均更高。
  • 心源性休克(OR 10.3,p=0.0001)、重度三尖瓣反流(OR 2.3,p=0.001)、急诊/紧急状态(OR 1.8,p=0.001)及合并冠状动脉旁路移植(OR 2.4,p=0.002)独立增加STS主要并发症与30天死亡复合风险。
  • 再次二尖瓣手术量每年增长10%,手术死亡率O/E比从研究早期1.44改善至最近时期0.72。

临床怎么用

  • 对拟行再次二尖瓣手术患者,应评估心源性休克、重度三尖瓣反流、急诊状态及是否合并CABG以识别高危人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Data suggest that redo mitral valve surgery is being performed in increasing numbers, possibly with superior results according to single-centre studies. The purpose of this study is to describe outcomes of redo mitral valve surgery and identify risk-adjusted predictors of poor outcomes. METHODS: All (11 973) open mitral valve cases were evaluated (2002-2016) from a regional Society of Thoracic Surgery (STS) database. Patients were stratified by primary versus redo mitral valve surgery. Mixed effects logistic regression models including hospital as a random effect were used to identify risk factors for patients undergoing redo mitral valve surgery. RESULTS: Of all mitral valve cases, 1096 (9.7%) had a previous mitral operation. Redo patients had higher rates of valve replacement and preoperative comorbidities resulting in more complications, operative mortalities (11.1%vs6.5%, p<0.0001) and higher resource utilisation. Several factors independently increased risk for composite STS major morbidity and 30-day mortality, including cardiogenic shock (OR 10.3, p=0.0001), severe tricuspid insufficiency (OR 2.3, p=0.001), urgent/emergent status (OR 1.8, p=0.001) and concurrent coronary artery bypass grafting (OR 2.4, p=0.002). The volume of redo mitral valve surgery increased 10% per year and the observed-to-expected ratios (O/E) for operative mortality in redo mitral surgery improved from 1.44 early in the study period to 0.72 in the most recent era. CONCLUSIONS: Redo mitral valve surgery accounts for approximately 10% of mitral valve operations and is associated with increased risk and resource utilisation. However, as the volume of redo mitral surgery increases, outcomes have dramatically improved and are now better than predicted.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Mehaffey HJ, Hawkins RB, Schubert S, et al. Contemporary outcomes in reoperative mitral valve surgery. Heart. 2017. PMID: 28982718. doi:10.1136/heartjnl-2017-312047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。